Bailard’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Buy
+54,592
New +$1.12M 0.02% 332
2026
Q2
– Sell
-50,692
Closed -$975K – 842
2026
Q1
$975K Buy
50,692
+3,972
+9% +$78.2K 0.02% 327
2025
Q4
$885K Sell
46,720
-1,300
-3% -$24.1K 0.02% 341
2025
Q3
$895K Buy
48,020
+1,300
+3% +$24.3K 0.02% 345
2025
Q2
$862K Hold
46,720
– – 0.02% 349
2025
Q1
$816K Buy
46,720
+33,383
+250% +$563K 0.02% 339
2024
Q4
$231K Sell
13,337
-1,345
-9% -$24.6K 0.01% 658
2024
Q3
$273K Hold
14,682
– – 0.01% 618
2024
Q2
$226K Hold
14,682
– – 0.01% 643
2024
Q1
$217K Buy
+14,682
New +$203K 0.01% 669
2022
Q3
– Sell
-24,020
Closed -$336K – 748
2022
Q2
$336K Buy
+24,020
New +$321K 0.01% 455
2022
Q1
– Sell
-37,025
Closed -$501K – 802
2021
Q4
$501K Buy
+37,025
New +$524K 0.02% 407
2020
Q4
– Sell
-15,100
Closed -$208K – 675
2020
Q3
$208K Buy
+15,100
New +$222K 0.01% 460
2020
Q1
– Sell
-22,700
Closed -$484K – 554
2019
Q4
$484K Buy
+22,700
New +$508K 0.03% 290

Other funds holding SBRA

Bailard's SBRA Position: Q3 2026 in Review

Bailard opened a new position in Sabra Healthcare REIT (SBRA) in Q3 2026: 54,592 shares worth $1.08M. The stake represents 0.02% of the portfolio and ranks #332 among its holdings. This is a return to the name: Bailard previously reported a position in SBRA as recently as Q1 2026.

Bailard first reported a position in SBRA in Q4 2019 and has held it in 14 quarters since. 55 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Bailard held 54,592 shares of Sabra Healthcare REIT worth $1.08M as of Q3 2026.
  • Sabra Healthcare REIT was a new Bailard position in Q3 2026.
  • Sabra Healthcare REIT made up 0.02% of Bailard's portfolio in Q3 2026, its #332 holding.
  • Bailard first reported a position in Sabra Healthcare REIT in Q4 2019 and has held it in 14 quarters since.
  • 55 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.